Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
about
The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio MirrorDirect oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.Influence of Inflammation and Atherosclerosis in Atrial Fibrillation.Blood markers of inflammation and endothelial dysfunction in cardioembolic stroke: systematic review and meta-analysis.Pharmacogenetics and precision medicine: Is inflammation a covert threat to effective genotype-based therapy?Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial.Possible Mediation by Methylation in Acute Inflammation Following Personal Exposure to Fine Particulate Air Pollution.Stratifying Stroke Risk in Atrial Fibrillation: Beyond Clinical Risk Scores.Inflammatory biomarkers in atrial fibrillation: are they linked to future outcomes?Postoperative Myocardial Injury and Inflammation Is Not Blunted by a Trial of Atorvastatin in Orthopedic Surgery Patients.A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score.Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) TriaInterleukin-37 elevation in patients with atrial fibrillation.Application of Light Scattering Techniques to Nanoparticle Characterization and Development.
P2860
Q26742118-386883EC-BC83-48AC-B3C4-42D20A6B2689Q39031152-40845B90-7519-47F2-9ED9-5D831C477B30Q39094801-383BF963-58E7-49F5-B2FD-47862B953DF7Q39100770-79DD88F8-C204-4C28-BB6F-F49E762A1A85Q42345777-9EADDED5-CD26-458A-A77F-7A011FB9F8ACQ47100046-9D8A49C7-8346-4D70-B01B-338BFF846BCBQ47666987-D135771C-3FF2-4F32-B36B-9B15C270F680Q48110503-ABD8644E-D03E-4920-808A-8FF4E480153BQ48220780-49FA9A94-7942-4F4B-958F-A24E69432B1CQ49336475-5B5E1BBA-5372-46C7-896F-9D44EDE74FEAQ50082606-897F4E01-8DB0-4EF2-9EC2-4252462D1160Q50119076-C0D03516-AE75-440F-B8A2-E602AD58D897Q50868896-DE57F98D-1FE0-40B0-8DC6-643C82A7FF57Q55516366-5DE38272-9C9C-412F-B775-037138AB6A76
P2860
Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Biomarkers of inflammation and ...... ents with atrial fibrillation.
@en
type
label
Biomarkers of inflammation and ...... ents with atrial fibrillation.
@en
prefLabel
Biomarkers of inflammation and ...... ents with atrial fibrillation.
@en
P2093
P2860
P50
P1433
P1476
Biomarkers of inflammation and ...... ents with atrial fibrillation.
@en
P2093
ARISTOTLE Investigators
Bernard Gersh
Elaine M Hylek
John H Alexander
John Horowitz
Julia Aulin
Michael Hanna
Renato D Lopes
Ulrika Andersson
Ziad Hijazi
P2860
P304
P356
10.1136/HEARTJNL-2015-308887
P407
P577
2016-02-02T00:00:00Z